Someone in the group asked a very good question:
Why does it take so long for a new therapy (with promising smaller studies backing it up) to get FDA approval and become standard of care?
——
The reason it takes a new therapy so long to get FDA approval is because the bar is extremely high.
There are three phases that must be completed. 1. Safety, 2. Preliminary efficacy, 3. Full efficacy. The whole process takes a decade or more and costs at least $100 million to fund the required studies. For some new therapies, it can cost nearly $1 billion. Almost all of this is spent on running the actual studies themselves.
The last phase 3 step usually requires a huge randomized, double-blind, placebo-controlled, multicenter trial that generally involves hundreds or thousands of people and runs for multiple years. This is what takes the longest. And it is very common for these phase 3 trials to fail, and for all the money to be lost— which is why most new therapies never get approved even though the earlier studies looked very promising. In many cases, the risk of failing in phase 3 is so high relative to the cost that you don’t even bother to try, even for therapies that do appear promising.
—-
On the other hand, the FDA does allow a physician to use any dietary supplement with GRAS status in their practice. They are also allowed to prescribe almost any drug off-label. For example, this means that they can take a drug that is only approved for cancer, and instead prescribe it for heart disease. This gives doctors a huge amount of flexibility to go beyond the standard of care if they choose to. Much of what we talk about in this group are therapies that go beyond the standard of care. The best doctors still use quality science and studies to decide how to best go beyond the standard of care. They are still very much science-based, even though that science often doesn’t meet the extremely rigorous criteria for full FDA approval.
